;PMID: 2087797
;source_file_1933.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..110] = [t:48..110]
;2)section:[e:114..134] = [t:114..134]
;3)section:[e:138..190] = [t:138..190]
;4)sentence:[e:194..438] = [t:194..438]
;5)sentence:[e:439..576] = [t:439..576]
;6)sentence:[e:577..852] = [t:577..852]
;7)sentence:[e:853..1095] = [t:853..1095]
;8)section:[e:1099..1143] = [t:1099..1143]

;section 0 Span:0..42
;Ukr Biokhim Zh. 1990 Nov-Dec;62(6):98-101.
(SEC
  (FRAG (NNP:[0..3] Ukr) (NNP:[4..11] Biokhim) (NNP:[12..14] Zh) (.:[14..15] .)
        (CD:[16..20] 1990) (.:[21..31] Nov-Dec;62) (-LRB-:[31..32] -LRB-)
        (CD:[32..33] 6) (-RRB-:[33..34] -RRB-) (CD:[34..38] :98-)
        (CD:[38..41] 101) (.:[41..42] .)))

;sentence 1 Span:48..110
;[Acetylenic amines as inhibitors of microsomal monooxygenases]
;[49..66]:substance:"Acetylenic amines"
;[70..80]:substance:"inhibitors"
;[95..109]:substance:"monooxygenases"
(SENT
  (NP-HLN (-LRB-:[48..49] -LSB-)
    (NP (JJ:[49..59] Acetylenic) (NNS:[60..66] amines))
    (PP (IN:[67..69] as)
      (NP
        (NP (NNS:[70..80] inhibitors))
        (PP (IN:[81..83] of)
          (NP (JJ:[84..94] microsomal) (NNS:[95..109] monooxygenases)))))
    (-RRB-:[109..110] -RSB-)))

;section 2 Span:114..134
;[Article in Russian]
(SEC
  (NP (-LRB-:[114..115] -LSB-)
    (NP (NN:[115..122] Article))
    (PP (IN:[123..125] in)
      (NP (NNP:[126..133] Russian)))
    (-RRB-:[133..134] -RSB-)))

;section 3 Span:138..190
;Kormilitsyn BN, Libman NM, Moralev SN, Rozengart VI.
(SEC
  (FRAG (NNP:[138..149] Kormilitsyn) (NNP:[150..152] BN) (,:[152..153] ,)
        (NNP:[154..160] Libman) (NNP:[161..163] NM) (,:[163..164] ,)
        (NNP:[165..172] Moralev) (NNP:[173..175] SN) (,:[175..176] ,)
        (NNP:[177..186] Rozengart) (NNP:[187..190] VI.)))

;sentence 4 Span:194..438
;A new class of compounds: acetylenic amines, possessing structural similarity
; with the known inhibitor SKF-525A, and their saturated analogues, has been 
;studied for its effect on the microsomal cytochrome P-450-dependent 
;monooxygenases (MM).
;[209..218]:substance:"compounds"
;[220..237]:substance:"acetylenic amines"
;[288..297]:substance:"inhibitor"
;[298..306]:substance:"SKF-525A"
;[328..337]:substance:"analogues"
;[379..432]:substance:"microsomal cytochrome P-450-dependent  monooxygenases"
;[434..436]:substance:"MM"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (DT:[194..195] A) (JJ:[196..199] new) (NN:[200..205] class))
        (PP (IN:[206..208] of)
          (NP (NNS:[209..218] compounds))))
      (::[218..219] :)
      (NP
        (NP
          (NP (JJ:[220..230] acetylenic) (NNS:[231..237] amines))
          (,:[237..238] ,)
          (VP (VBG:[239..249] possessing)
            (NP
              (NP (JJ:[250..260] structural) (NN:[261..271] similarity))
              (PP (IN:[273..277] with)
                (NP (DT:[278..281] the) (VBN:[282..287] known)
                    (NN:[288..297] inhibitor) (NN:[298..306] SKF-525A))))))
        (,:[306..307] ,) (CC:[308..311] and)
        (NP (PRP$:[312..317] their) (VBN:[318..327] saturated)
            (NNS:[328..337] analogues))))
    (,:[337..338] ,)
    (VP (VBZ:[339..342] has)
      (VP (VBN:[343..347] been)
        (VP (VBN:[349..356] studied)
          (NP-1 (-NONE-:[356..356] *))
          (PP (IN:[357..360] for)
            (NP
              (NP (PRP$:[361..364] its) (NN:[365..371] effect))
              (PP (IN:[372..374] on)
                (NP
                  (NP (DT:[375..378] the)
                     (JJ:[379..389] microsomal)
                    (ADJP
                      (NML (NN:[390..400] cytochrome) (NN:[401..406] P-450))
                      (HYPH:[406..407] -) (JJ:[407..416] dependent))
                    (NNS:[418..432] monooxygenases))
                  (NP (-LRB-:[433..434] -LRB-) (NN:[434..436] MM)
                      (-RRB-:[436..437] -RRB-)))))))))
    (.:[437..438] .)))

;sentence 5 Span:439..576
;Significant differences in sensitivity of different  substrate oxidation
;reactions in experiments with the mouse liver MM were  observed.
;[492..501]:substance:"substrate"
;[558..560]:substance:"MM"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJ:[439..450] Significant) (NNS:[451..462] differences))
      (PP (IN:[463..465] in)
        (NP
          (NP (NN:[466..477] sensitivity))
          (PP (IN:[478..480] of)
            (NP (JJ:[481..490] different) (NN:[492..501] substrate)
                (NN:[502..511] oxidation) (NNS:[512..521] reactions)))))
      (PP-LOC (IN:[522..524] in)
        (NP
          (NP (NNS:[525..536] experiments))
          (PP (IN:[537..541] with)
            (NP (DT:[542..545] the) (NN:[546..551] mouse) (NN:[552..557] liver)
                (NN:[558..560] MM))))))
    (VP (VBD:[561..565] were)
      (VP (VBN:[567..575] observed)
        (NP-1 (-NONE-:[575..575] *))))
    (.:[575..576] .)))

;sentence 6 Span:577..852
;It was shown that the acetylenic amines investigated 13-30 times  exceeded
;their saturated analogues as to the ability to inhibit aminopyrine and 
;benzo[a]pyrene oxidation, and differed but slightly from their analogues with
; respect to p-nitroanisole and paraoxon oxidation.
;[599..616]:substance:"acetylenic amines"
;[630..641]:quantitative-value:"13-30 times"
;[668..677]:substance:"analogues"
;[707..718]:substance:"aminopyrine"
;[724..738]:substance:"benzo[a]pyrene"
;[787..796]:substance:"analogues"
;[814..828]:substance:"p-nitroanisole"
;[833..841]:substance:"paraoxon"
(SENT
  (S
    (NP-SBJ-3
      (NP (PRP:[577..579] It))
      (SBAR-4 (-NONE-:[579..579] *ICH*)))
    (VP (VBD:[580..583] was)
      (VP (VBN:[584..589] shown)
        (NP-3 (-NONE-:[589..589] *))
        (SBAR-4 (IN:[590..594] that)
          (S
            (NP-SBJ
              (NP (DT:[595..598] the)
                 (JJ:[599..609] acetylenic) (NNS:[610..616] amines))
              (VP (VBN:[617..629] investigated)
                (NP (-NONE-:[629..629] *))))
            (VP
              (VP
                (NP-EXT
                  (QP (CD:[630..632] 13) (HYPH:[632..633] -) (CD:[633..635] 30))
                  (NNS:[636..641] times))
                (VBD:[643..651] exceeded)
                (NP (PRP$:[652..657] their) (VBN:[658..667] saturated)
                    (NNS:[668..677] analogues))
                (PP (IN:[678..680] as)
                  (PP (TO:[681..683] to)
                    (NP (DT:[684..687] the) (NN:[688..695] ability)
                      (S
                        (NP-SBJ (-NONE-:[695..695] *))
                        (VP (TO:[696..698] to)
                          (VP (VB:[699..706] inhibit)
                            (NP
                              (NP (NN:[707..718] aminopyrine)
                                (NML-2 (-NONE-:[718..718] *P*)))
                              (CC:[719..722] and)
                              (NP (NN:[724..738] benzo-LSB-a-RSB-pyrene)
                                (NML-2 (NN:[739..748] oxidation)))))))))))
              (,:[748..749] ,) (CC:[750..753] and)
              (VP (VBD:[754..762] differed)
                (ADVP (RB:[763..766] but) (RB:[767..775] slightly))
                (PP (IN:[776..780] from)
                  (NP (PRP$:[781..786] their) (NNS:[787..796] analogues)))
                (PP (IN:[797..801] with)
                  (NP
                    (NP (NN:[803..810] respect))
                    (PP (TO:[811..813] to)
                      (NP
                        (NP (NN:[814..828] p-nitroanisole)
                          (NML-1 (-NONE-:[828..828] *P*)))
                        (CC:[829..832] and)
                        (NP (NN:[833..841] paraoxon)
                          (NML-1 (NN:[842..851] oxidation)))))))))))))
    (.:[851..852] .)))

;sentence 7 Span:853..1095
;Benzo[a]pyrene hydroxylase of  the house-fly abdomens was less sensitive to
;the compound investigated than that  of the mouse liver, however, in contrast
;to it exhibited selectively to the  diphenyl derivatives and not to the
;monophenyl ones.
;[853..879]:cyp450:"Benzo[a]pyrene hydroxylase"
;[933..941]:substance:"compound"
;[1043..1063]:substance:"diphenyl derivatives"
;[1052..1063]:substance:"derivatives"
;[1079..1089]:substance:"monophenyl"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[853..867] Benzo-LSB-a-RSB-pyrene) (NN:[868..879] hydroxylase))
      (PP (IN:[880..882] of)
        (NP (DT:[884..887] the)
          (NML (NN:[888..893] house) (HYPH:[893..894] -) (NN:[894..897] fly))
          (NNS:[898..906] abdomens))))
    (VP
      (VP (VBD:[907..910] was)
        (ADJP-PRD
          (ADJP (RBR:[911..915] less) (JJ:[916..925] sensitive))
          (PP (TO:[926..928] to)
            (NP (DT:[929..932] the) (NN:[933..941] compound)
                (VBN:[942..954] investigated)))
          (PP (IN:[955..959] than)
            (NP
              (NP (DT:[960..964] that))
              (PP (IN:[966..968] of)
                (NP (DT:[969..972] the) (NN:[973..978] mouse)
                    (NN:[979..984] liver)))))))
      (,:[984..985] ,)
      (VP
        (ADVP (RB:[986..993] however))
        (,:[993..994] ,)
        (PP (IN:[995..997] in)
          (NP
            (NP (NN:[998..1006] contrast))
            (PP (TO:[1007..1009] to)
              (NP (PRP:[1010..1012] it)))))
        (VP (VBD:[1013..1022] exhibited)
          (ADVP (RB:[1023..1034] selectively))
          (PP=2 (TO:[1035..1037] to)
            (NP (DT:[1038..1041] the)
               (NN:[1043..1051] diphenyl) (NNS:[1052..1063] derivatives))))
        (CC:[1064..1067] and)
        (VP (RB:[1068..1071] not)
          (PP=2 (TO:[1072..1074] to)
            (NP (DT:[1075..1078] the) (NN:[1079..1089] monophenyl)
                (NNS:[1090..1094] ones))))))
    (.:[1094..1095] .)))

;section 8 Span:1099..1143
;PMID: 2087797 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1099..1103] PMID) (::[1103..1104] :) (CD:[1105..1112] 2087797)
        (NN:[1113..1114] -LSB-) (NNP:[1114..1120] PubMed) (::[1121..1122] -)
        (NN:[1123..1130] indexed) (IN:[1131..1134] for)
        (NNP:[1135..1143] MEDLINE-RSB-)))
